Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Masterflex SE specializes in the production of high-quality flexible tubing and connection systems primarily for the pharmaceutical and biotechnology sectors. Its competitive position is bolstered by a strong focus on innovation and customization, enabling it to serve clients in Europe and North America effectively.
Masterflex generates revenue through the sale of specialized tubing and connection systems, leveraging its expertise in materials science to offer customized solutions. The company's strong R&D capabilities allow for premium pricing, particularly in regulated industries where quality and compliance are paramount.
Demand for biopharmaceutical manufacturing supplies
Regulatory changes impacting the pharmaceutical sector
Raw material price fluctuations, particularly plastics and elastomers
Innovation in product offerings and successful new product launches
Technological disruption in manufacturing processes
Regulatory changes that could increase compliance costs
Emerging competitors offering lower-cost alternatives
Consolidation in the pharmaceutical sector reducing customer base
Low liquidity due to minimal operating cash flow
Potential for increased raw material costs impacting margins
moderate - the company is somewhat sensitive to economic cycles, as demand for its products is linked to the health of the pharmaceutical and biotech industries, which can be cyclical.
Interest rates affect Masterflex primarily through financing costs for any potential expansions or R&D investments. Higher rates could constrain capital availability, impacting growth initiatives.
minimal - the company's low debt-to-equity ratio (0.20) suggests it is not heavily reliant on credit for operations.
growth - due to the company's focus on innovation and expanding into high-demand sectors like biotechnology.
moderate - historical volatility has been consistent with industry trends, but specific events can lead to sharp movements.
